Perioperative biobehavioral interventions to prevent cancer recurrence through combined inhibition of β-adrenergic and cyclooxygenase 2 signaling.
Perioperative biobehavioral interventions to prevent cancer recurrence through combined inhibition of β-adrenergic and cyclooxygenase 2 signaling.
复制标题
DOI:
10.1002/cncr.31594
复制
发表时间:
2019-01-01
期刊:
影响因子:
6.2
通讯作者:
Ben-Eliyahu, Shamgar
中科院分区:
文献类型:
--
作者:
Ricon, Itay;Hanalis-Miller, Tsipi;Haldar, Rita;Jacoby, Rebecca;Ben-Eliyahu, Shamgar
关键词:
Evidence suggests that excess perioperative activation of the sympathetic nervous system (SNS) and the consequent release of catecholamines (i.e., epinephrine and norepinephrine) in the context of cancer surgery and inflammation may significantly facilitate pro-metastatic processes. This review first presents biomedical processes that make the perioperative timeframe pivotal in determining long-term cancer outcomes, non-proportionally to its short duration (days-weeks). We then analyze the various mechanisms via which excess release of catecholamines can facilitate progression of cancer metastases in this context, through directly affecting the malignant tissues, and through indirect pathways, regulating immunological and other mechanisms that affect metastatic progression in the tumor microenvironment and systemically. Additionally, we address the need to supplement β-adrenoreceptor blockade with COX2 inhibition, especially during surgery and shortly thereafter, given that similar mechanisms are simultaneously activated by surgery-induced inflammatory responses. Importantly, we present translational and clinical evidence that perioperative β-adrenoreceptor blockade and COX2 inhibition can reduce pro-metastatic process and cancer recurrence, and the clinical feasibility and safety of this approach. Last, we present psycho-physiological alternative approaches to the use of β-adrenergic blockers, as a substantial portion of patients have medical contraindications to this pharmacological treatment. Adaptation of existing psycho-physiological interventions to the perioperative period, as well as principles of constructing new approaches are discussed and exemplified. Overall, pharmaco-behavioral interventions, separately or combined, could transform the perioperative timeframe from being a prominent facilitator of metastatic progression, to an opportunity for arresting or eliminating residual disease, potentially improving long-term survival rates in cancer patients. Evidence based on animal models, retrospective clinical studies, and recently also randomized controlled trials (RCTs), indicate that simultaneous use of beta-blockers and COX2 inhibitors can effectively reduce pro-malignant effects of perioperative stress-inflammatory responses, and may reduce patients recurrence rates and mortality. Hypothetically, perioperative psychological interventions may have similar benefits.
登录
查看更多内容
影响因子:
10.6
作者:
Antoni, Michael H.;Lutgendorf, Susan K.;Blomberg, Bonnie;Carver, Charles S.;Lechner, Suzanne;Diaz, Alain;Stagl, Jamie;Arevalo, Jesusa M. G.;Cole, Steven W.
通讯作者:
Cole, Steven W.
影响因子:
4.2
作者:
Choy C;Raytis JL;Smith DD;Duenas M;Neman J;Jandial R;Lew MW
通讯作者:
Lew MW
影响因子:
6.7
作者:
Cata, Juan P.;Villarreal, John;Gottumukkala, Vijaya
通讯作者:
Gottumukkala, Vijaya
影响因子:
4.7
作者:
Al-Niaimi, Ahmed;Dickson, Elizabeth L.;Mc Nally, Amy
通讯作者:
Mc Nally, Amy
影响因子:
45.3
作者:
Barron, Thomas I.;Connolly, Roisin M.;Visvanathan, Kala
通讯作者:
Visvanathan, Kala